Complete inhibition of in vivo glioma growth by oncostatin M

被引:26
作者
Friedrich, M
Höss, N
Stögbauer, F
Senner, V
Paulus, W
Ringelstein, EB
Halfter, H
机构
[1] Univ Munster, Dept Neurol, D-48129 Munster, Germany
[2] Univ Munster, Dept Neurosurg, D-48129 Munster, Germany
[3] Univ Munster, Dept Neuropathol, D-48129 Munster, Germany
关键词
antitumorigenic; glioblastoma; in vivo; oncostatin M; tetracycline-inducible expression;
D O I
10.1046/j.1471-4159.2001.00202.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe here the oncostatin M (OSM)-dependent inhibition of in vivo tumour formation after intracerebral inoculation of glioblastoma cells in mice. We generated human glioblastoma cells transfected with the OSM gene under the control of a tetracycline-response promoter. Upon removal of tetracycline from the medium, cells exhibited a differentiated cell morphology, while proliferation was significantly inhibited. After implantation of these cells into nude mice brains, large tumours developed in animals lacking OSM expression, whereas no tumour formation was observed in mice with induced OSM expression. Our results suggest that OSM exerts pronounced antitumorigenic effects on glioblastoma cells in vivo and provide arguments for a therapeutic application of OSM in humans.
引用
收藏
页码:1589 / 1592
页数:4
相关论文
共 22 条
[1]   Gene therapy of experimental brain tumors using neural progenitor cells [J].
Benedetti, S ;
Pirola, B ;
Pollo, B ;
Magrassi, L ;
Bruzzone, MG ;
Rigamonti, D ;
Galli, R ;
Selleri, S ;
Di Meco, F ;
De Fraja, C ;
Vescovi, A ;
Cattaneo, E ;
Finocchiaro, G .
NATURE MEDICINE, 2000, 6 (04) :447-450
[2]   MORPHOLOGICAL, IMMUNOCYTOCHEMICAL AND GROWTH-CHARACTERISTICS OF 3 HUMAN GLIOBLASTOMAS ESTABLISHED INVITRO [J].
BILZER, T ;
STAVROU, D ;
DAHME, E ;
KEIDITSCH, E ;
BURRIG, KF ;
ANZIL, AP ;
WECHSLER, W .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 418 (04) :281-293
[3]  
BRUCE AG, 1992, J IMMUNOL, V149, P1271
[4]  
Chang PL, 1997, ANN NY ACAD SCI, V831, P461
[5]  
Douglas AM, 1998, INT J CANCER, V75, P64, DOI 10.1002/(SICI)1097-0215(19980105)75:1<64::AID-IJC11>3.0.CO
[6]  
2-D
[7]   Oncostatin M:: Signal transduction and biological activity [J].
Gómez-Lechón, MJ .
LIFE SCIENCES, 1999, 65 (20) :2019-2030
[8]   The oncostatin M signalling pathway: reversing the neoplastic phenotype? [J].
Grant, SL ;
Begley, CG .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :406-412
[9]  
Halfter H, 1999, Mol Cell Biol Res Commun, V1, P109, DOI 10.1006/mcbr.1999.0117
[10]   Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on Stat3 or on mitogen-activated protein kinase activation [J].
Halfter, H ;
Stögbauer, F ;
Friedrich, M ;
Serve, S ;
Serve, H ;
Ringelstein, EB .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) :973-981